Bringing the fundamentals into focus…
Back to Crinetics Pharmaceuticals Inc
How Crinetics Pharmaceuticals Inc stacks up
CRNX · against 172 other Healthcare companies of similar size
Profitability
2/ 100
Near the bottom of its peers.
Ranked #172 of 173 · scores higher than 0% of peers
Bars: peers in each 10-point band of the profitability score7 peers with a profitability score of 0–9, including CRNX · Click a bar to see the companies
Why profitability scores 2?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 98% of peers. Operating margin: -6714.8% vs peer median 7.1%
- a lower return on invested capital: weaker than 98% of peers. Return on invested capital: -480.1% vs peer median 4.7%
- a lower return on assets: weaker than 84% of peers. Return on assets: -26.3% vs peer median 1.7%
Metric by metric
Position: dot = CRNX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CRNX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 168 reported | -480.1% | 10.0% | 1% | 33% | |
| Operating marginHigher is better · 165 reported | -6714.8% | 12.9% | 1% | 33% | |
| Return on assetsHigher is better · 165 reported | -26.3% | 4.5% | 9% | 33% | |
| Return on equityHigher is better · 160 reported | -42.4% | 8.9% | 11% | Context only | |
| Gross marginHigher is better · 182 reported | 0.0% | 54.2% | 2% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around CRNX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 13.9B EUR (≈$15.3B) | 99 | 78 | |
| 1 | 20.0B AUD (≈$13.2B) | 99 | 77 | |
| 4 | 548.2B INR (≈$6.6B) | 98 | 68 | |
| 4 | 170.4B THB (≈$4.8B) | 98 | 70 | |
| 168 | 5.4B USD | 8 | 24 | |
| 169 | 5.7B USD | 5 | 52 | |
| 169 | 4.8B USD | 5 | 27 | |
| 169 | 4.6B USD | 5 | 29 | |
| 172 | 9.0B USD | 2 | 51 | |
| 172 | 8.7B USD | 2 | 26 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score